MODY/LADA

Lilly Jaffe, of Chicago, was diagnosed with type 1 diabetes more than ten years ago, at the tender age of one month. What has happened to Lilly over the past few years is remarkable….

Insulin-Pump Therapy + New Types of Insulin Preparations + Complications of Insulin Therapy, Chapter 9 – Part 6 Steve V. Edelman, MD Robert R. Henry, MD Insulin-Pump Therapy Insulin-pump therapy has been traditionally used for people with Type 1 diabetes. People with Type 1 diabetes usually do not have insulin …

Insulin Therapy, Chapter 9 – Part 1 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego   Insulin therapy most commonly is reserved for patients …

New clinical study shows patients with Type 2 diabetes may be able to tolerate higher doses of metformin using GLUMETZA…. 

By Sheri Colberg, PhD   Q: Dr. Sheri, I’ve been doing a lot of research on Type 2 diabetes and exercise. I have had Type 2 for five years.  I am preparing for my first marathon. (I have raced halfs, 10K’s, 5K’s, etc….) My question relates to fasting insulin levels.  I was …

Parents who live in fear of their children having hypoglycemic episodes might have a negative effect on their child’s diabetes control, says a new study. Good provision of psychological support for parents and their children with diabetes is therefore crucial….

A panel of diabetes experts is encouraging efforts to increase understanding of the heterogeneity of Type 2 diabetes to achieve individualized treatments and improve treatment responses….

The FDA warned 17 food makers — including POM and Nestle — that their “misleading” product labels violate federal law. The warning letters say the firms face having their products pulled from grocery shelves if they don’t make changes….

The FDA and manufacturer of the HomeChoice and HomeChoice PRO dialysis systems have notified patients of a class I device recall — the FDA’s most serious — after a number of reported injuries and one death….

“Avosentan reduces albuminuria when added to standard treatment in people with Type 2 diabetes and overt nephropathy but induces significant fluid overload and congestive heart failure,” the study authors write. “Of particular concern was a trend to a higher mortality with avosentan….